|
Hui-Kuo George
Shu, M.D., Ph.D.
Associate
Professor
Education
and Degrees
·
1983-1986, B.A., Washington
University.
·
1986-1991, Ph.D., Case Western
Reserve University, Advisor: Hsing-Jien Kung, PhD.
·
1986-1993, M.D., Case Western
Reserve University.
Certification
- American Board of Radiology, Radiation Oncology, 1999
Training
·
University Hospitals of Cleveland,
Intern in Medicine, 07/1993-06/1994.
·
UCSF, Resident in Radiation
Oncology, 07/1994-06/1999.
·
UCSF, Brain Tumor Research Center,
Research Fellow, 07/1995-06/1997
Special
Interests
- My focus is on the study of
brain tumors. Clinically, I
hope to improve therapy by participating in various cooperative group
trials. In the lab, I hope to
gain a greater understanding of how malignant gliomas
arise and how they respond to inhibition of the epidermal growth
factor receptor.
Selected
Recent Publications
o
Tykocinski,
M.L., Shu, H.-K.G., Ayers, D.J.,
Walter, W.I., Getty, R.K., Groger, C.A., Hauer, and Medof, M.E., 1988,
Glycolipid Reanchoring
of T-Lymphocyte Surface Antigen CD8 Using the 3’ End Sequence of Decay-Accelerating
Factors mRNA, Proc. Natl. Acad. Sci. USA, 85, 3555-3559.
o
Hambor,
J.E., Hauer, C.A., Shu, H.-K.G., Groger, R.K., Kaplan,
D.R., and Tykocinski, M.L., 1988, Use of Epstein-Barr
Virus Episomal Replicon
for Anti-Sense RNA-Mediated Gene Inhibition in a Human Cytoxic
T-Cell Clone, Proc. Natl. Acad. Sci. USA, 85, 4010-4014.
o Pelley,
R.J., Maihle, N.J., Boerkoel,
C., Shu, H.K.G., Carter, C., Moscovici, and Hung, H.-J., 1989, Disease Tropism of c-erbB: Effects
of Carboxyl-Terminal Tyrosine and Internal Mutations on Tissue-Specific
Transformation, Proc. Natl. Acad. Sci. USA, 86, 7164-7168.
o Kung,
H.-J., Pelley, R.J., Shu, H.K.G., Maihle, M.A., Raines,
Carter, T.H., Boerkoel, C., Moscovici,
G., and Moscovici, C., 1990, Retroviral Insertional Mutagenesis: The Making of a Receptor-Oncogene, Develop. Biol. Standard, 72, 139-144.
o Shu, H.-K.G., Pelley,
R.J. and Kung, H.-J., 1990, Tissue Specific Transformation by epidermal
growth factor receptor: A Single Point Mutation within the ATP-Binding
Pocket of the erbB
Product Increases its Intrinsic Kinase Activity
and Activates its Sarcomagenic Potential, Proc.
Natl. Acad. Sci. USA, 87, 9103-9107.
o Shu, H.-K.G., Pelley,
R.J., and Kung, H.-J., 1991, Dissecting the
Activating Mutations in v-erbB of AEV-R, J. Virol., 65,
6173-6180.
o Shu, H.-K.G., Chang,
C.-M., Ravi, L., Ling, L., Castellano, C.M.,
Walter, E., Pelley, R.J., and Kung, H.-J., 1994, Modulation
of erbB
Kinase Activity and Oncogenic
Potential by Single Point Mutations in the Glycine
Loop of the Catalytic Domain, Mol. Cell. Biol., 14, 6868-6878.
o Chang,
C.-M., Shu, H.-K.G., Ravi, L., Pelley, R.J., Shu, H., and Kung, H.-J., 1995,A Minor
Tyrosine Phosphorylation Site Localized within
the CAIN Domain Plays a Critical Role in Regulating Tissue-Specific
Transformation by erbB
Kinase, J. Virol., 69,
1172-1180.
o Chang,
C.-M., Shu, H.-K.G., and Kung,
H.-J. Disease Specificity of Kinase Domain: Src Catalytic
Domain Converts erbB
into a Sarcoma Oncogene, 1995, Proc. Natl. Acad.
Sci. USA, 92, 3928-3932.
o Shu, H.-K.G., Sneed,
P.K., Shiau, C.Y., McDermott, M.W., Lamborn, K.R., Park, E., Ho, M., Petti,
P.L., Smith, V., Verhey, L.J.,Wara,
W.M., Gutin, P.H., and Larson, D.A., 1996, Factors
Influencing Survival after Gamma Knife Radiosurgery
for Patients with Single and Multiple Brain Metastases, Cancer J. from Sci.
Amer., 2, 335-342.
o Shiau,
C.Y., Sneed, P.K., Shu, H.-K.G., Lamborn, K.R., McDermott, M.W., Chang, S., Nowak, P., Petti, P.L., Smith, V., Verhey,
L.J., Ho, M., Park, E., Wara, W.M., Gutin, P.H., and Larson, D.A., 1997, Radiosurgery for Brain Metastases: Relationship of Dose
and Pattern of Enhancement to Local Control, Int. J. Rad. Onc. Bio. Phys., 37, 375-383.
o Seung,
S.K., Sneed, P.K., McDermott, M.W., Shu,
H.-K.G., Leong, S., Chang, S., Petti, P.L.,
Smith, V., Verhey, L.J., Wara,
W.M., Phillips,. T.L., and Larson, D.A., 1998, Gamma-Knife
Radiosurgery for Melanoma Brain Metastases,
Cancer J. from Sci. Amer., 4, 103-109.
o Florio,
M., Hernandez, M.C., Yang, H., Shu,
H.-K.G., Cleveland, J.L., and Israel, M.A., 1998, Id2 Promotes
Apoptosis by a Novel Mechanism Independent of Dimerization
to Basic Helix-Loop-Helix Factors, Mol. Cell Bio., 18, 5435-5444.
o Shu, H.-K.G.,
Kim, M.M., Furman, F., Julin, C.M., and Israel,
M.A., 1998, The Intrinsic Radioresistance of Glioblastoma-Derived Cell Lines is Associated with a
Failure of p53 to Induce p21BAX Expression, Proc. Natl. Acad.
Sci. USA, 95, 14453-14458.
o
Shu,
H.-K.G., Julin, C.M. ,
Furman, F., Yount, G.L., Haas-Kogan,
D., and Israel, M.A., 2000, Overexpression of
E2F-1 in Glioma-Derived Cell Lines Induces a
p53-Independent Apoptosis that is Further Enhanced by Ionizing Radiation, Neuro-Oncology, 2, 16-21.
o Sultanem,
K., Shu, H.-K., Xia, P., Akazawa, C., Quivey, J.M., Verhey, L.J., and Fu, K.K., 2000, Three-Dimensional
Intensity-Modulated Radiotherapy in the Treatment of Nasopharyngeal
Carcinoma: The University of California-San Francisco Experience, Int. J.
Rad. Onc. Bio. Phys., 48, 711-722.
o Le,
Q.-T., Takamiya, R., Shu, H.-K., Smitt, M., Singer, M., Terris, D. J., Fee, W. E., Goffinet,
D. R., and Fu, K.K., 2000, Treatment Results of Carcinoma In Situ of the Glottis:An Analysis of 82 Cases, Arch. Otolaryngol. Head Neck Surg., 126, 1305-1312.
o Shu, H.-K.G.,
Lee, T.T., Vigneault, E., Xia, P., Pickett, B.,
Phillips, T.L., and Roach, M., 2001, Toxicity Following High-Dose
Three-Dimensional Conformal and Intensity-Modulated Radiation Therapy for
Clinically Localized Prostate Cancer, Urology, 57, 102-107.
o Lee,
T.T., Everett, D.L., Shu, H.-K.,
Jahan, T.M., Roach, M., Speight, J.L.,Cameron, R.B., Phillips, T.L.,Chan, A. and Jablons,
D.M., 2002, Radical Pleurectomy/Decortication and Intraoperative
Radiotherapy Followed by Conformal Radiation with and without Chemotherapy
for Malignant Pleural Mesothelioma, J. Thorac. Cardiovasc. Surg.,
124, 1183-1189.
o Chen, C., Shu, H.-K.G., Goldwein, J.W., Womer, R.B., and Maity A., 2003,
Volumetric considerations in radiotherapy for pediatric parameningeal
rhabdomyosarcomas, Int. J. Rad. Onc. Bio. Phys., 55, 1294-1299.
o Li, B., Chang, C.-M., Yuan, M., McKenna, W.G., and Shu, H.-K.G., 2003, Resistance to small molecule
inhibitors of epidermal growth factor receptor in malignant gliomas, Cancer Res., 63, 7443-7450.
o Stripp,
D.C.H., Maity, A., Janss,
A.J., Belasco, J.B., Tochner, Z.A., Goldwein, J.W., Moshang, T., Rorke, L.B., Phillips, P.C., Sutton, L.N., and Shu,
H.-K.G., 2004, Surgery
with or without radiation therapy in the management of craniopharyngiomas
in children and young adults, Int. J. Rad. Onc. Bio. Phys., 58, 714-720.
o Maity,
A., Shu, H.-K.G., Janss, A.J., Belasco, J.B., Rorke,
L.B., Phillips, P.C., Sutton, L.N., and Goldwein,
J.W., 2004, Craniospinal Radiation in the Treatment of Biopsy
Proven Intracranial Germinomas: Twenty-five years
experience in a single center, Int. J. Rad. Onc. Bio. Phys., 58, 1165-1170.
o Li, B., Yuan, M., Kim, I.-A., Chang, C.-M.,
Bernhard, E.J.., and Shu, H.-K.G., 2004, Mutant epidermal growth factor
receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance
in cells of astrocytic origin, Oncogene, 26, 4594-4602.
o Bucci,
M.K., Maity, A., Janss,
A.J., Belasco, J.B., Fisher, M.J., Tochner, Z.A.,
Rorke, L.B., Sutton, L.N., Phillips, P.C., and Shu, H.-K.G., 2004, Near complete surgical resection predicts a favorable
outcome in pediatric non-brainstem, malignant gliomas:
Results from a single center in the MRI era, Cancer, 15, 817-824.
o Maity,
A., Shu, H.-K.G., Judkins, A.R., Fisher,
M.J., Dwyer-Joyce, L.E.A., and Vaughn, D.J., 2004, Testicular seminoma sixteen years after treatment for CNS germinoma, J. Neuro-oncology,
70, 83-85.
o Pore,
N., Liu, S., Shu, H.-K., Li, B., Haas-Kogan,
D., Stokoe, D., Milanini-Mongiat,
J., Pages, G., O’Rourke, D.M., Bernhard, E. and Maity,
A., 2004, Sp1 is involved in Akt-mediated
induction of VEGF expression through a HIF-1 independent mechanism,
Molecular Biology of the Cell, 15, 4841-4853.
o Fisher,
M.J., Lange, B.J., Needle, M.N., Janss, A.J., Shu,
H.-K.G., Adamson, P.C. and Phillips, P.C., 2004, Amifostine
for children with medulloblastoma treated with cisplatin-based chemotherapy, Pediatric Blood and
Cancer, 43, 780-784.
o Maity,
A., Shu, H.-K.G., Tan, J., Ruffer, J.,
Sutton, L.N., Tochner, Z.A., and Lustig, R., 2004, Treatment of pediatric intracranial arteriovenous malformations with linear accelerator
based stereotactic radiosurgery: the University
of Pennsylvania experience, Pediatric Neurosurgery, 40, 207-214.
o
Pore, N.,
Jiang, Z., Shu, H.-K., Bernhard, E., Kao, G.D., and Maity, A., 2006, AKT activation can augment hypoxia-inducible
factor-1 alpha expression by increasing protein translation through a
mammalian Target Of Rapamycin-independent
pathway, Molecular Cancer Research, 4, 471-479.
|